| Medical and Health Sciences | Lifetime | 518 | US 280 | 99.98 |
| Medical and Health Sciences | 2021-2025 | 548 | US 190 | 99.88 |
| Nephrology | Lifetime | 11 | US 7 | 99.91 |
| Pulmonary and Respiratory Medicine | Lifetime | 550 | US 294 | 99.22 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 542 | US 292 | 98.32 |
| Hematology | Lifetime | 456 | US 222 | 97.15 |
| Transplantation | Lifetime | 406 | US 185 | 84.79 |
| Nephrology | 2021-2025 | 22 | US 10 | 99.54 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 118 | US 59 | 98.27 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 445 | US 146 | 95.25 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 654 | US 279 | 88.30 |
| Hematology | 2021-2025 | 330 | US 156 | 83.51 |
| Dialysis and Renal Disease Management | Lifetime | 9 | US 5 | 99.91 |
| Parathyroid Disorders and Treatments | Lifetime | 8 | US 8 | 99.77 |
| Chronic Kidney Disease and Diabetes | Lifetime | 14 | US 10 | 99.83 |
| Iron Metabolism and Disorders | Lifetime | 36 | US 20 | 99.46 |
| Potassium and Related Disorders | Lifetime | 12 | US 9 | 99.74 |
| Electrolyte and hormonal disorders | Lifetime | 35 | US 18 | 99.29 |
| Erythropoietin and Anemia Treatment | Lifetime | 35 | US 15 | 99.15 |
| Neurological and metabolic disorders | Lifetime | 42 | US 17 | 98.69 |
| Vitamin D Research Studies | Lifetime | 158 | US 72 | 98.60 |
| Magnesium in Health and Disease | Lifetime | 42 | US 16 | 98.08 |
| Blood Pressure and Hypertension Studies | Lifetime | 406 | US 178 | 98.78 |
| Diabetes Treatment and Management | Lifetime | 346 | US 137 | 98.68 |
| Pharmacological Effects and Toxicity Studies | Lifetime | 358 | US 145 | 98.16 |
| Renal function and acid-base balance | Lifetime | 168 | US 93 | 97.82 |
| Nutrition and Health in Aging | Lifetime | 537 | US 203 | 98.11 |
| Hemoglobinopathies and Related Disorders | Lifetime | 537 | US 270 | 97.35 |
| Acute Kidney Injury Research | Lifetime | 317 | US 136 | 96.77 |
| Muscle and Compartmental Disorders | Lifetime | 169 | US 71 | 96.49 |
| Central Venous Catheters and Hemodialysis | Lifetime | 558 | US 249 | 96.36 |
| Renal Transplantation Outcomes and Treatments | Lifetime | 846 | US 414 | 97.12 |
| Renal Diseases and Glomerulopathies | Lifetime | 917 | US 306 | 96.22 |
| Membrane-based Ion Separation Techniques | Lifetime | 556 | US 84 | 95.66 |
| Dialysis and Renal Disease Management | 2021-2025 | 14 | US 5 | 99.57 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 29 | US 12 | 99.18 |
| Electrolyte and hormonal disorders | 2021-2025 | 19 | US 7 | 97.29 |
| Potassium and Related Disorders | 2021-2025 | 20 | US 10 | 97.97 |
| Hormonal Regulation and Hypertension | 2021-2025 | 112 | US 32 | 95.67 |
| Diabetes Treatment and Management | 2021-2025 | 312 | US 107 | 96.53 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 327 | US 123 | 95.05 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 45 | US 18 | 94.41 |
| Parathyroid Disorders and Treatments | 2021-2025 | 154 | US 45 | 94.57 |
| Iron Metabolism and Disorders | 2021-2025 | 257 | US 104 | 91.89 |
| Renal function and acid-base balance | 2021-2025 | 100 | US 34 | 85.83 |
| Magnesium in Health and Disease | 2021-2025 | 207 | US 39 | 67.63 |
| Ion Transport and Channel Regulation | 2021-2025 | 446 | US 140 | 65.58 |
